Zaloguj Zarejestruj się zadarmo

Novabay Pharmaceuticals Inc organizacji Przychody Q/Q

Jaka jest wartość Przychody Q/Q organizacji Novabay Pharmaceuticals Inc?

Wartość Przychody Q/Q organizacji Novabay Pharmaceuticals Inc to -47.94%

Jaka jest definicja Przychody Q/Q?

Perspektywiczna kwartalna stopa wzrostu z roka (Estimated quarterly EPS growth rate) rok do roku, to szacowany wzrost wartości EPS spółki na następny kwartał w porównaniu do wyników z poprzedniego kwartału.

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

Przychody Q/Q firm w Health Care sektor na NYSEMKT w porównaniu do Novabay Pharmaceuticals Inc

Czym się zajmuję organizacja Novabay Pharmaceuticals Inc?

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Firmy z przychody q/q podobne do Novabay Pharmaceuticals Inc